• COVID-19
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
    • Corporate TB Pledge
    • Urban Health
    • Inclusive Development
  • PHC INNOVATIONS
  • LEARNING LIBRARY
  • DATA VISUALIZATION

This section hosts guidelines, manuals and toolkits to strengthen public health practice.

Resources

FILTER
BY CATEGORY

View All

COVID-19 Stay Tuned Nutrition For implementers For policymakers Report For researchers Research Urban Health M&E

EXPLORE DATA
VISUALIZATIONS

Explore key data on health and its determinants in India through interactive graphs.

First Non prescription COVID-19 Test That Also Detects Flu and RSV

14 Jul 2022
Emerging Pandemics

by −Howard D. Larkin 5 MIN

The first non-prescription COVID-19 test that also detects the flu and RSV is discussed in this article. The FDA has approved the first non-prescription diagnostic test that can recognize several viruses, including respiratory syncytial virus, that cause respiratory symptoms similar to COVID-19 (RSV). FDA experts regard it as a further development toward the ability to diagnose certain infections at home. Customers will be able to more readily establish whether they have RSV, influenza, or SARS-CoV-2 infection thanks to the multianalyte test. Following consultation with a medical practitioner, test findings can assist consumers in deciding whether they should self-isolate or take other health care measures. We are getting closer to tests for these viruses that might be completed totally at home because to the quick advancements being made in consumer access to diagnostic tests, including the ability to collect your sample at home for the flu and RSV without a prescription.

Related File :

9618870704.pdf

Categories

COVID-19
KEY ORGANIZATIONS
Connect with Us
Subscribe to the Newsletter

FOLLOW US

  • HOME
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
  • LEARNING LIBRARY
  • DATA VISUALIZATION
  • ABOUT US
  • CONTACT US
  • PRIVACY POLICY
Disclaimer: This website is made possible by the support of the American People through the United States Agency for International Development (USAID). The Learning4impact partnership is supported by USAID/India Health Office, under Cooperative Agreement # 72038618CA00001 with Swasti. The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of USAID, the United States Government, or Swasti.
Copyright 2025 Swasti Health Catalyst

Subscribe to the Newsletter

Submit Feedback

  • COVID-19
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
    • Corporate TB Pledge
    • Urban Health
    • Inclusive Development
  • PHC INNOVATIONS
  • LEARNING LIBRARY
  • DATA VISUALIZATION